Stock screener

CYTK

Conviction 53HealthcareScan · Tue, Sep 8, 2026
CYTK$75.36+3.63%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
63 bars
Gilbert Cisneros
2
Vol MA14 1.83M
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
CYTOKINETICS INCPHARMACEUTICAL PREPARATIONSwww.cytokinetics.com ↗
Price75.36
Change+3.63%
Gap-0.36%
Rel volume1.41×
Avg volume1.79M
Avg $ vol133.3M
SMA 2075.17
SMA 5079.05
SMA 20069.81
Price vs 50-4.67%
Price vs 200+7.95%
MA stackmixed
50/200 cross—
Supertrenddown · 78.72
RSI (14)49
MACD hist-0.07
MACD crossbear · 6d
Stoch %K / %D57 / 44
ADX (14)14
+DI / −DI23 / 23
RSI divergence—
MACD divergenceBullish
ATR %+3.74%
ADR %3.19%
52w high87.26
52w low47.56
From 52w high-13.64%
Above 52w low+58.45%
New 52w highNo
SqueezeOff
Bollinger width12.66%
%B0.52
Donchian pos57.26%
Donchian high79.88
Donchian low69.31
AVWAP (52w high)78.82
vs AVWAP high-4.39%
AVWAP (52w low)68.93
vs AVWAP low+9.33%
OBV trendFlat
Chaikin MF (20)-0.03
Today vs 20d1.41×
Avg vol (14d)1.83M
Avg vol (20d)1.79M
Avg $ vol (20d)133.3M
Market cap10.48B
RS 3m (vs SPY)-2.69%
RS 6m (vs SPY)+5.83%
RS line new highNo
Trend template6/8
Technical rank57.8
1 week+6.28%
1 month-1.82%
3 months+10.99%
6 months+20.73%
1 year+42.16%
YTD+22.08%
P/E-13.35
P/B-60.39
P/S119.00
P/FCF-19.59
EPS-6.54
Div yield—
ROE452.46%
ROA-40.79%
Debt/Eq-1.59
Current6.66
EV/EBITDA-17.43
Gross margin—
Net margin-891.60%
Rev growth376.56%
EPS growth-33.15%
Price target111.38
Target upside47.80%
Analyst ratingBuy
Institutional123.77%
Ent. value10.5B
Revenue28.62M
Net income-198.76M
Gross profit—
Free cash flow-534.82M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out124.43M
Employees673
ListedThu, Apr 29, 2004
Free float120.88M
Float %97.3%
Short interest16.32M
Days to cover7.7d
Short volume53.2%
Squeeze score67 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$1.50 vs −$1.63
Last surprise+8.0% beat
Setup gradeC
Conviction53 / 100
Pattern quality—
Tech rank57.8 / 100
Group rank96 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance83.77
Support70.72
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in CYTK · 4 recent

All disclosures →
MemberSideAmount
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2026-06-30
Buy$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · CA · traded 2025-10-09
Buy$1K–$15K
Lisa McClain
Lisa McClain
house · R · MI · traded 2025-06-17
Sell$1K–$15K
Lisa McClain
Lisa McClain
house · R · MI · traded 2025-06-11
Buy$1K–$15K

Insider activity

SEC Form 4 transactions in CYTK · 3 buys · 7 sells

InsiderSideShares
PARSHALL B LYNNE
Director · Common Stock · 2026-09-01
Sell5K
Blum Robert I
President & CEO · Common Stock · 2026-08-31
Exercise7.5K
Blum Robert I
President & CEO · Common Stock · 2026-08-31
Sell7.5K
Blum Robert I
President & CEO · Non-Qualified Stock Option (Right to Buy) · 2026-08-31
Exercise7.5K
Callos Andrew
EVP, Chief Commercial Officer · Common Stock · 2026-08-31
Exercise10K
Callos Andrew
EVP, Chief Commercial Officer · Common Stock · 2026-08-31
Sell10K
Callos Andrew
EVP, Chief Commercial Officer · Non-Qualified Stock Option (Right to Buy) · 2026-08-31
Exercise10K
Malik Fady Ibraham
EVP Research & Development · Common Stock · 2026-08-18
Exercise3.5K
Malik Fady Ibraham
EVP Research & Development · Common Stock · 2026-08-18
Sell3.5K
Malik Fady Ibraham
EVP Research & Development · Non-Qualified Stock Option (Right to Buy) · 2026-08-18
Exercise3.5K

SEC filings

EDGAR filings in CYTK · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.